Sartans in the Treatment of Hypertension
We recommend
Can Antihypertensives Reduce the Risk of Dementia? The Answer Suggests the Angiotensin Hypothesis and a Post-Hoc Analysis of an Observational Study
The use of antihypertensives that do not reduce angiotensin II levels, such as angiotensin receptor blockers (ARBs, i.e., sartans) and calcium channel blockers (CCBs), has been associated with a lower risk of dementia in studies. In the research cited below, the authors aimed to determine whether this effect persists longer than the follow-up period in previous studies.
Association Between Sartan Therapy and Lower Incidence of Epilepsy in Hypertensive Patients?
Arterial hypertension (AH) is one of the non-cerebral comorbidities of epilepsy, with the…
The main advantage of sartans is a very good safety profile. Now it is about increasing adherence in hypertensive patients
The rules for initiating hypertension treatment have been simplified. The trend is to achieve blood…
Articles on this topic
Effect of Telmisartan and Losartan on Bone Turnover Markers in Patients with Newly Diagnosed Stage I Hypertension
Telmisartan, an AT1 receptor blocker for angiotensin II and partial agonist of the PPAR-γ…
The Anti-inflammatory and Renoprotective Effect of Candesartan May Be Independent of the AT1 Receptor
Candesartan belongs to the blockers of AT1 receptors (AT1R) for angiotensin II coupled with G…
Can antihypertensive treatment also have a beneficial effect on neurocognitive functions?
Observational studies suggest that a desirable side effect of AT1 receptor blockers for…
Are there mutual interactions between candesartan and amlodipine in the combination therapy of hypertension?
Monotherapy is often insufficient in the treatment of hypertension; however, combining…
Can sartans improve clinical outcomes in hypertensive patients with COVID-19?
Dysfunction of the renin-angiotensin system (RAS) has been detected in patients with COVID-19.…
Candesartan is beneficial in heart failure with mildly reduced ejection fraction
Analysis of data from the CHARM study showed that in patients with heart failure with mildly…
Candesartan Could Ameliorate the Cytokine Storm in COVID-19 Infection
Scientists from Bethesda, USA, experimentally found the upregulation of the same genes during…
Fixed Combination of Candesartan/Amlodipine in the Treatment of Arterial Hypertension
Arterial hypertension is a significant cardiovascular risk factor. A variety of…
Adequate Compensation of a Hypertensive Patient According to Current ESC Guidelines – Case Study
A 65-year-old man, hypertensive, visits the general practitioner for a check-up. He reports recent...
About Sartans: An Overview with Consideration of Their Position in the Current Coronavirus Situation
Sartans, or AT1 receptor blockers for angiotensin II (ARBs), are among the first-line…
Subscribe
Most read on this topic
Journal on this topic
Related topic
Interesting links
Most read on this topic
- About Sartans: An Overview with Consideration of Their Position in the Current Coronavirus Situation
- Adequate Compensation of a Hypertensive Patient According to Current ESC Guidelines – Case Study
- Candesartan Could Ameliorate the Cytokine Storm in COVID-19 Infection
- Fixed Combination of Candesartan/Amlodipine in the Treatment of Arterial Hypertension
- Telmisartan – antihypertensive with cardioprotective effects
- Impact of ACEi and ARBs on Lung Function in Patients with Hypertension
Journal on this topic
Related topic
Interesting links